Interestingly, a previous study demonstrated that cryptotanshinone, similar to DHTS in structure, was found to inhibit phosphorylation of AKT and S6RP in human rhabdomyosarcoma and prostate cancer cells by not altering the protein expression of p110.52 The gene discussed is AKT1; the disease is prostate carcinoma.